CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Moderna Therapeutics against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 7, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Rna-Coded AntibodyCUREVACAug 24, 2022

Explore Moderna Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid Compositions10
Feb 23, 2022Terminally Modified Rna1
Aug 25, 2021Compositions Comprising Synthetic Polynucleotides Encoding Crispr Related Proteins And Synthetic Sgrnas And Methods Of Use2
Mar 4, 2020Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof2

Top competitors of Moderna Therapeutics

List of top competitors of Moderna Therapeutics based on patent oppositions.